-+ 0.00%
-+ 0.00%
-+ 0.00%

Pasithea Therapeutics Corp. Receives FDA Orphan Drug Designation For MEK1/2 Inhibitor For Treatment Of Amyotrophic Lateral Sclerosis

Benzinga·05/29/2026 17:52:07
Listen to the news